![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, December 01, 2020 2:44:33 PM
My post:
At the very end of the article Woodun does say:
Finally, Relief has a strong vaccine candidate based on the fact that it uses VIP, which was present in significantly higher levels in the blood samples of those patients who did NOT die because of respiratory failure.
In response to your post I looked back again and it has been changed to:
Finally, Relief has a strong drug candidate based on the fact that it uses VIP, which was present in significantly higher levels in the blood samples of those patients who did NOT die because of respiratory failure.
So it has obviously been corrected. I wasn't sure why he brought in the vaccine reference when I read it and I posted it only to point out that statement was in there as some indicated. I didn't post it because I agreed with him. I did wonder if he would elaborate on that at some future time but now it is clear that comment was a mistake.
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM